Physician profile
Azamuddin Khaja
NPI 1699723486
$21,484.98
in general payments reported to CMS, 2019-2025
49 companies · $2,560 in 2025
The $2,560 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,212 · 2020: $2,077 · 2021: $2,671 · 2022: $4,070 · 2023: $4,830 · 2024: $3,065 · 2025: $2,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,456 · Travel and Lodging: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,456.37 |
| Travel and Lodging | $999.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,557.55 | 2021-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Amgen INC. | $1,790.71 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $1,713.27 | 2019-2024 | Xarelto |
| Medtronic, INC. | $1,523.21 | 2022-2025 | Micra, Onyx Frontier, Venaseal |
| Philips North America LLC | $1,463.35 | 2020-2025 | (9520) Igt Devices Undivided, (Bs1) Peripheral Vascular Undivided, Igt Devices Undivided |
| Boston Scientific Corporation | $1,349.83 | 2019-2025 | Watchman Access System, Watchman Flx |
| Actelion Pharmaceuticals US, INC. | $1,267.94 | 2019-2023 | Uptravi, Opsumit |
| Novartis Pharmaceuticals Corporation | $1,231.12 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,016.56 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $979.17 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $939.63 | 2019-2025 | Brilinta, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $821.29 | 2019-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $820.40 | 2019-2025 | Lifevest |
| Abbott Laboratories | $614.61 | 2019-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Merck Sharp & Dohme LLC | $423.97 | 2021-2025 | Verquvo, Winrevair |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azamuddin Khaja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.